The lungs' ability to expand and contract with each breath depends on a fragile molecular film lining the alveoli — and emerging biophysical evidence suggests that two widely used vaping additives may undermine that film's structural integrity. Understanding precisely how inhaled compounds disturb this interface could reshape how clinicians interpret vaping-associated lung injury and how regulators assess additive safety.
Using Langmuir-Pockels trough technology and oscillatory barrier deformations designed to replicate the mechanical cycles of breathing, researchers examined how cannabidiol (CBD) and α-tocopherol (vitamin E acetate) alter the behavior of dipalmitoylphosphatidylcholine (DPPC) monolayers — the dominant phospholipid in lung surfactant. Both compounds disrupted lipid packing, surface pressure behavior, and dilatational rheology in a concentration-dependent fashion. Epifluorescence microscopy revealed changes in lipid domain morphology that correlated with compromised surface activity. Critically, vitamin E exerted a stronger destabilizing effect than CBD across all concentrations tested, and the combination of both additives produced effects that differed from either compound alone — suggesting interactive rather than simply additive interference with surfactant mechanics.
This work matters because EVALI, which emerged prominently around 2019 and was epidemiologically linked to vitamin E acetate in illicit THC cartridges, still lacks a fully characterized molecular mechanism. Prior histopathological and epidemiological work implicated lipid-soluble additives, but biophysical modeling of the surfactant interface adds a mechanistic layer previously missing. The DPPC monolayer is an established, though simplified, proxy for the alveolar lining — real lung surfactant contains additional proteins and phospholipids that modulate behavior in ways this in vitro model cannot fully capture. Translating monolayer biophysics to human pulmonary function requires caution: concentration levels at the alveolar surface during actual vaping remain difficult to quantify. Nevertheless, the finding that vitamin E is more disruptive than CBD — and that combined exposure compounds the dysfunction — is a meaningful incremental advance that lends biophysical plausibility to epidemiological EVALI signals and strengthens the case for rigorous additive-specific safety evaluation.